NCT02372448View on ClinicalTrials.gov

Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

January 23, 2015

Primary Completion Date

November 21, 2019

Study Completion Date

November 21, 2019

Conditions
Lung Neoplasms
Interventions
OTHER

ALK analysis on CTCs detected by ISET

Trial Locations (11)

13915

Marseille University Hospital, Marseille

14000

Centre François Baclesse, Caen

31059

Toulouse University Hospital, Toulouse

38043

Grenoble university hospital, Grenoble

54500

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

54511

Nancy university hospital, Nancy

75020

Hôpital Tenon, Paris

94800

Institut Gustave Roussy, Villejuif

06100

Centre Antoine Lacassagne, Nice

Unknown

CHU de Nice, Nice

06700

Institut arnault tzanck, Saint-Laurent-du-Var

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02372448 - Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients | Biotech Hunter | Biotech Hunter